Boundless Bio Appoints New Board Members and Establishes Clinical Advisory Board

James Christensen, Ph.D., and Nancy Whiting, Pharm.D., join Board of DirectorsGeorge Demetri, M.D., to serve as first member of Clinical Advisory BoardSAN DIEGO--(BUSINESS WIRE)--Boundless Bio, a clinical stage, next-generation precision oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver...

Related Keywords

United Kingdom ,United States ,British ,American ,Nancy Whiting ,Zachary Hornby ,Jamie Christensen ,James Christensen ,James Jamie Christensen ,James Lee ,Warner Lambert Parke Davis ,Recludix Pharma ,Oncology Research Unit At Pfizer ,Professor Of Medicine At Harvard Medical School ,Carolina State University ,University Of Washington Hospitals In Seattle ,University Of Washington ,Harvard Medical School ,University Of British Columbia ,Sarcoma Center ,Harvard College ,Clinical Development ,Northern Illinois University ,Pfizer ,Linkedin ,Stanford University School Of Medicine ,Ludwig Center At Harvard ,Sarcoma Center At Dana Farber Cancer Institute ,Dana Farber Cancer Institute ,Twitter ,Seattle Cancer Care Alliance ,Clinical Advisory ,Boundless Bio ,Chief Scientific Officer ,Mirati Therapeutics ,Chief Executive Officer ,George Demetri ,Oncology Precision Medicine ,Oncology Research Unit ,Cancer Cell ,Cancer Discovery ,New England Journal ,North Carolina State University ,Northern Illinois ,Executive Vice President ,Corporate Strategy ,Senior Vice President ,Medical Affairs ,Seattle Cancer Care ,Quick Family Chair ,Medical Oncology ,Ludwig Center ,Stanford University School ,Washington Hospitals ,Harvard Medical ,Science Policy ,Government Affairs Committee ,American Association ,Cancer Research ,